KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Tax Provisions (2016 - 2025)

Amgen has reported Tax Provisions over the past 17 years, most recently at $181.0 million for Q4 2025.

  • Quarterly results put Tax Provisions at $181.0 million for Q4 2025, up 16.77% from a year ago — trailing twelve months through Dec 2025 was $1.3 billion (up 143.74% YoY), and the annual figure for FY2025 was $1.3 billion, up 143.74%.
  • Tax Provisions for Q4 2025 was $181.0 million at Amgen, down from $705.0 million in the prior quarter.
  • Over the last five years, Tax Provisions for AMGN hit a ceiling of $705.0 million in Q3 2025 and a floor of $45.0 million in Q1 2024.
  • Median Tax Provisions over the past 5 years was $212.5 million (2021), compared with a mean of $226.2 million.
  • Biggest five-year swings in Tax Provisions: plummeted 92.51% in 2024 and later soared 440.0% in 2025.
  • Amgen's Tax Provisions stood at $232.0 million in 2021, then tumbled by 43.1% to $132.0 million in 2022, then plummeted by 35.61% to $85.0 million in 2023, then skyrocketed by 82.35% to $155.0 million in 2024, then increased by 16.77% to $181.0 million in 2025.
  • The last three reported values for Tax Provisions were $181.0 million (Q4 2025), $705.0 million (Q3 2025), and $136.0 million (Q2 2025) per Business Quant data.